Clever Culture Systems LimitedASX: CC5

Novo Nordisk Expand Use of APAS Independence

· Issued by Clever Culture Systems Limited

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Clever Culture Systems Limited has announced a purchase order from Novo Nordisk for two additional APAS® Independence instruments, increasing their total to three instruments at Novo Nordisk. This order includes the development of custom laboratory interface software to facilitate global deployment of the APAS® technology. The order is seen as an early indication of a positive sales outlook for the upcoming fiscal year, driven by the company's Land and Expand strategy targeting major pharmaceutical manufacturers. The instruments will be used for formal validation of the APAS® technology at a site in Denmark, supporting regulatory compliance for Good Manufacturing Practice.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Clever Culture Systems Limited on 6ix

Story so far

Earlier from Clever Culture Systems

Later from Clever Culture Systems

All Clever Culture Systems news releases